AI HEALTH TECH (01715) announced that with global demographic changes and rising health awareness, the healthcare industry is experiencing unprecedented development opportunities. Particularly in China, as the aging process accelerates and digital technology becomes widely adopted, the healthcare market represented by the "silver economy" continues to expand. To actively respond to the national "Healthy China" strategic direction, while maintaining all existing businesses, the Group is focusing on healthcare, digital medicine and wellness services based on its existing health-related operations, building a full-cycle health service ecosystem covering "prevention-diagnosis and treatment-medication-rehabilitation-nursing", expecting this segment to make greater contributions to the Group's revenue.
1. Empowering the Health Industry with Artificial General Intelligence (AGI) and Digitalization to Create an Intelligent Health Management Platform
The Group has recently completed the establishment of its wholly-owned subsidiary Shenzhen Candong Health Technology Co., Ltd., and assembled a research and development team composed of professionals in software engineering, data science, health management and other fields. This team will focus on health data analysis and intelligent services, developing a one-stop health management platform that supports real-time monitoring of health data for all populations and full life cycles through a combination of independent research and development and third-party technology licensing. Leveraging Artificial General Intelligence (AGI) technology, the platform will deliver healthy lifestyle concepts to users.
The platform plans to integrate functions including dynamic vital sign monitoring, intelligent risk assessment, personalized health intervention and medication reminders, and will connect to medical institutions, wellness service institutions and home-based elderly care scenarios according to the plan. To continuously advance technology iteration and platform optimization, the Group plans to further increase investment in system construction in the fields of artificial general intelligence and big data in the health sector over the next three years. It is expected that after the platform is officially put into operation, it will significantly enhance the Group's revenue annually and gradually form a dual-driven profit model of technology output and service subscription.
2. Expanding into High-end Medical Care and Wellness Industry to Build a Silver Economy Collaborative System
To address the growing demand for high-quality wellness services, the Group is actively expanding its business depth in the medical care and wellness sector. To date, the Group has signed strategic cooperation agreements with multiple companies including Sinopharm Zhongkang (Guangxi) Health Industry Co., Ltd. and Anhui Baqianli Technology Development Co., Ltd., and established joint ventures in Anhui to jointly explore business opportunities in biomedicine, rehabilitation nursing, and health management in Greater China.
The cooperation will be advanced through the establishment of joint ventures, fully leveraging each party's resource advantages in research and development, production, and channels. The Group will focus on leveraging its distribution network in the Guangdong-Hong Kong-Macao Greater Bay Area and mainland cities, responsible for market promotion and sales of related products. According to current plans, the relevant joint ventures are expected to generate positive cash flow for the Group by 2026.
3. Strengthening Health and Personal Care Product Trading, Improving Channel and Supply Chain Layout
Based on research predictions from institutions such as Frost & Sullivan, China's health industry and silver economy continue to grow, with enormous market potential for age-appropriate health and personal care products. To precisely capture niche market demands, the Group will integrate its existing resource advantages and strengthen its layout in e-commerce channels (including Tmall, JD.com, Douyin, Dewu, etc.), while gradually establishing a product supply chain system covering both online and offline channels.
Currently, the Group has reached preliminary cooperation intentions with multiple quality suppliers from mainland China, Hong Kong, Japan, South Korea, the United States and the European Union, planning to introduce multi-category personal health care products. Based on current market research and sales forecasts, this business segment is expected to generate stable revenue for the Group in Q4 2025, and gradually achieve scale and certain market share in 2026 and 2027.
This business expansion represents an important strategic initiative formulated by the Group based on market trends and its own resource advantages, aiming to build a complete business chain covering health management, wellness services, and product trading through the dual-driven approach of "technology + health" and "products + services". In the future, the Group will continue to increase investment in digitalization, artificial general intelligence, biotechnology and other areas, continuously enhancing comprehensive service capabilities and industry competitiveness.
The Group firmly believes that the above layout will not only help enrich the existing business structure and cultivate new profit growth points, but will also create long-term sustainable value for shareholders and investors.